Core Viewpoint - The stock of Hema Technology Co., Ltd. experienced a decline of 3.92% on October 17, with a trading volume of 177 million yuan and a total market capitalization of 13.285 billion yuan [1] Company Overview - Hema Technology Co., Ltd. specializes in the research, manufacturing, and sales of photovoltaic inverter products, energy storage products, and electrical equipment [2][7] - The company's main products include micro-inverters, monitoring equipment, distributed photovoltaic power generation systems, modular inverters, and other power conversion devices [2][7] - The company has been recognized as a "specialized, refined, distinctive, and innovative" small giant enterprise, indicating its strong market position and innovation capabilities [2] Financial Performance - For the first half of 2025, Hema Technology reported a revenue of 1.005 billion yuan, representing a year-on-year growth of 10.78%, while the net profit attributable to shareholders decreased by 91.33% to 16.2716 million yuan [8] - As of June 30, the number of shareholders was 9,849, a decrease of 5.73% from the previous period, with an average of 12,597 circulating shares per person, an increase of 6.08% [8] Market Dynamics - The company benefits from a significant overseas revenue share of 64.25%, aided by the depreciation of the RMB [3] - On March 5, 2025, Hangkai Holdings Group announced plans to increase its stake in Hema Technology, with an investment ranging from 111.5 million yuan to 223 million yuan, supported by a special loan from China CITIC Bank [3] Technical Analysis - The average trading cost of Hema Technology's shares is 111.61 yuan, with recent reductions in shareholding but at a slowing rate; the current stock price is near a support level of 106.60 yuan [6]
禾迈股份跌3.92%,成交额1.77亿元,近5日主力净流入-2041.64万